WHO | Definitions
– CIOMS - Council of International Organizations of Medical Sciences – ICH - International Conference on Harmonisation. 3 Pharmacovigilance WHO, 2002 • The science and activities relating to the detection, assessment, understanding …
Download WHO | Definitions
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Good, Practices, Pharmaceutical, Good distribution practices for, Distribution
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating
Related documents
International Ethical Guidelines for Health ... - CIOMS
cioms.chCIOMS, in association with WHO, undertook its work on ethics in biomedical research in the late 1970s. Accordingly, CIOMS set out, in cooperation with WHO, to prepare guidelines. The aim of the guidelines was (and still is) to provide internationally vetted …
International, Guidelines, Ethical, Icom, International ethical guidelines for
M4E(R2) - Common technical document for the registration ...
www.ema.europa.euM4E(R2) - Common technical document for the registration of pharmaceuticals for human use – Efficacy EMA/CPMP/ICH/2887/1999 Page 2/53 M4E(R1)
What is CIOMS?
www.ema.europa.euCIOMS II - International Reporting of Periodic Drug Safety Update Summaries (1992) CIOMS III - Guidelines for Preparing Core Clinical Safety Information on Drugs (1995) CIOMS IV 01/1995 –07/1997 Benefit-risk balance for marketed drugs (1998) CIOMS V 04/1997 –08/2000 Current Challenges in Pharmacovigilance: Pragmatic Approaches (1999) CIOMS ...
Defi nition and Application of Terms for Vaccine ...
www.who.intCIOMS thanks especially those members who chaired the meetings of the Working Group for their dedication and capable leadership. Each of the meetings had a nominated rapporteur (or rapporteurs), and CIOMS ac-knowledges their professional contributions. The Editorial Group, comprising Drs Adwoa D Bentsi-Enchill, Priya Bahri,
POST-APPROVAL SAFETY DATA MANAGEMENT EFINITIONS …
database.ich.orgPOST-APPROVAL SAFETY DATA MANAGEMENT: DEFINITIONS AND STANDARDS FOR EXPEDITED REPORTING ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 12 November 2003, this guideline is recommended for adoption to the three regulatory parties to ICH
Definition of Ethics (1)
www.ph.ucla.edu(CIOMS) Guidelines 1993, 2002 Nuremberg => Helsinki => CIOMS • Informed consent • Research in developing countries • Protection of vulnerable populations • Distribution of the burdens and benefits • Role and responsibilities of ethics committees. BASIC CONCEPTS OF ETHICAL RESEARCH.
CIOMS Form
www.cioms.chTitle: CIOMS Form Author: CIOMS Subject: Suspect Adverse Reaction Report Keywords: CIOMS, Adverse Reaction Report, Suspect, Form Created Date: 6/8/2017 7:25:55 AM
GUIDANCE FOR INDUSTRY
www.hsa.gov.sgGuidance for Industry – Post-marketing Vigilance Requirements for Therapeutic Products and CTGTP 01 March 2021 2 PREFACE This document is intended to provide general guidance. Although we have tried to ensure that the information contained here is accurate, we do not, however, warrant